| scholarly article | Q13442814 |
| P2093 | author name string | T Nakai | |
| S C Park | |||
| M Fukunaga | |||
| I Shimamura | |||
| K I Mori | |||
| P2860 | cites work | Pseudomonas plecoglossicida sp. nov., the causative agent of bacterial haemorrhagic ascites of ayu, Plecoglossus altivelis | Q28145175 |
| Enterococcus seriolicida sp. nov., a fish pathogen | Q33374058 | ||
| Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. | Q34179620 | ||
| Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa | Q34331837 | ||
| Long-circulating bacteriophage as antibacterial agents | Q34378378 | ||
| Isolation and characterization of bacteriophage PM2 from Aeromonas hydrophila | Q38341563 | ||
| Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. | Q39552106 | ||
| Isolation of Yersinia ruckeri Bacteriophages | Q40060991 | ||
| INDIGENOUS MARINE BACTERIOPHAGES. | Q40256761 | ||
| Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential | Q41542875 | ||
| Treatment of experimental infections of mice with bacteriophages | Q43585007 | ||
| Factors influencing the survival and multiplication of bacteriophages in calves and in their environment | Q44036193 | ||
| Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics | Q48987694 | ||
| The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. | Q54407609 | ||
| Effectiveness of Phages in Treating Experimental Escherichia coli Diarrhoea in Calves, Piglets and Lambs | Q54493566 | ||
| Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail | Q78105469 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fish | Q152 |
| bacteriophage | Q165028 | ||
| Pseudomonas plecoglossicida | Q7255090 | ||
| fish pathogen | Q124308732 | ||
| P304 | page(s) | 1416-1422 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Applied and Environmental Microbiology | Q4781593 |
| P1476 | title | Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control | |
| P478 | volume | 66 |
| Q54405123 | Application of a group II Campylobacter bacteriophage to reduce strains of Campylobacter jejuni and Campylobacter coli colonizing broiler chickens. |
| Q37017500 | Approaches for reducing Salmonella in pork production |
| Q37470848 | Bacteriophage and their lysins for elimination of infectious bacteria |
| Q38760149 | Bacteriophage biocontrol in wastewater treatment |
| Q36128582 | Bacteriophage control of foodborne bacteriat |
| Q26998710 | Bacteriophage remediation of bacterial pathogens in aquaculture: a review of the technology |
| Q34553978 | Bacteriophage therapy of infectious diseases in aquaculture |
| Q39799157 | Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens |
| Q38975521 | Bacteriophages and its applications: an overview |
| Q34126072 | Bacteriophages of Pseudomonas |
| Q36152181 | Biodiversity of bacteriophages: morphological and biological properties of a large group of phages isolated from urban sewage |
| Q54332159 | Biosafety evaluation of bacteriophages for treatment of diarrhea due to intestinal pathogen Escherichia coli 3-2 infection of chickens. |
| Q40465988 | Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli. |
| Q46081059 | Characterization of a serine hydroxymethyltransferase for L-serine enzymatic production from Pseudomonas plecoglossicida |
| Q44172769 | Characterization of a virulent bacteriophage LK1 specific for Citrobacter freundii isolated from sewage water |
| Q39742861 | Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. |
| Q34933970 | Complete genome sequence analysis of two Pseudomonas plecoglossicida phages, potential therapeutic agents |
| Q34595583 | Detection and quantification of Flavobacterium psychrophilum-specific bacteriophages in vivo in rainbow trout upon oral administration: implications for disease control in aquaculture |
| Q23920569 | Diagnostic and therapeutic applications of lytic phages |
| Q37125312 | Dispersal and survival of Flavobacterium psychrophilum phages in vivo in rainbow trout and in vitro under laboratory conditions: implications for their use in phage therapy. |
| Q91687866 | Diversification of Vibrio anguillarum Driven by the Bacteriophage CHOED |
| Q42235988 | Diversity and geographical distribution of Flavobacterium psychrophilum isolates and their phages: patterns of susceptibility to phage infection and phage host range |
| Q40783515 | Effect of Bacteriophages on the Growth of Flavobacterium psychrophilum and Development of Phage-Resistant Strains |
| Q36234256 | Effect of dietary probiotic supplementation on intestinal microbiota and physiological conditions of Nile tilapia (Oreochromis niloticus) under waterborne cadmium exposure |
| Q40114141 | Efficacy of potential phage cocktails against Vibrio harveyi and closely related Vibrio species isolated from shrimp aquaculture environment in the south east coast of India |
| Q43856464 | Evaluation of the influence of bacteriophage titer on the treatment of colibacillosis in broiler chickens |
| Q26773623 | Evolution of probiotics in aquatic world: Potential effects, the current status in Egypt and recent prospectives |
| Q36736576 | Expression and lytic efficacy assessment of the Staphylococcus aureus phage SA4 lysin gene |
| Q90418186 | Galactosylated wall teichoic acid, but not lipoteichoic acid, retains InlB on the surface of serovar 4b Listeria monocytogenes |
| Q95577303 | Genomic characterization of a novel virulent phage infecting the Aeromonas hydrophila isolated from rainbow trout (Oncorhynchus mykiss) |
| Q44879629 | Induction and characterization of lysogenic bacteriophages from Streptococcus iniae. |
| Q35947807 | Isolation and Characterization of Two Lytic Bacteriophages, φSt2 and φGrn1; Phage Therapy Application for Biological Control of Vibrio alginolyticus in Aquaculture Live Feeds |
| Q36553015 | Isolation and Characterization of a Myoviridae MJ1 Bacteriophage Against Multi-Drug Resistant Escherichia coli 3 |
| Q41901971 | Isolation and characterization of a T7-like lytic phage for Pseudomonas fluorescens. |
| Q36746710 | Isolation and characterization of bacteriophages infecting the fish pathogen Flavobacterium psychrophilum |
| Q42264152 | Isolation and characterization of five lytic bacteriophages infecting a Vibrio strain closely related to Vibrio owensii |
| Q28484243 | Isolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii |
| Q39704070 | Isolation and partial characterization of a virulent bacteriophage IHQ1 specific for Aeromonas punctata from stream water |
| Q90397735 | Isolation, Characterization, and Application of a Bacteriophage Infecting the Fish Pathogen Aeromonas hydrophila |
| Q38958623 | Isolation, characterization and therapeutic potential assessment of bacteriophages virulent to Staphylococcus aureus associated with goat mastitis |
| Q30847192 | Multiple enzyme restriction fragment length polymorphism analysis for high resolution distinction of Pseudomonas (sensu stricto) 16S rRNA genes |
| Q35076244 | Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish. |
| Q82823387 | Occurrence of Vibrio parahaemolyticus and its specific phages from shrimp ponds in east coast of India |
| Q36922172 | Optimization of bacteriocin production by Lactobacillus sp. MSU3IR against shrimp bacterial pathogens |
| Q37389925 | Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. |
| Q34612392 | Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae production |
| Q34181298 | Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice |
| Q35089166 | Pharmacokinetic principles of bacteriophage therapy. |
| Q38807711 | Probiotics as beneficial microbes in aquaculture: an update on their multiple modes of action: a review. |
| Q57275607 | Probiotics in aquaculture |
| Q79423611 | Reinventing phage therapy: are the parts greater than the sum? |
| Q57940652 | Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy |
| Q38539558 | The use of probiotics in aquaculture |
| Q64906072 | Ultra structural characteristics of methicillin resistant Staphylococcus aureus cell wall after affecting with lytic bacteriophages using atomic force microscopy. |
| Q34885744 | Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. |
| Q35531270 | Virulence reduction in bacteriophage resistant bacteria |
| Q49640242 | Whole-Genome Sequence of the Novel Enterobacter Bacteriophage Arya with an Integrase Pseudogene, Isolated from the Gut of the Formosan Subterranean Termite |
| Q39751592 | Wide geographic distribution of bacteriophages that lyse the same indigenous freshwater isolate (Sphingomonas sp. strain B18). |
Search more.